Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine
Authors
Keywords
Adenosine, Diabetes mellitus, Infarct size, Ischemia-reperfusion, Ticagrelor, Statin
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume 30, Issue 6, Pages 539-550
Publisher
Springer Nature
Online
2016-11-10
DOI
10.1007/s10557-016-6701-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective
- (2016) Ø. Sandanger et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse
- (2016) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Platelet P2Y12Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human ModelSignificance
- (2015) Mark R. Thomas et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Ticagrelor Protects the Heart Against Reperfusion Injury and Improves Remodeling After Myocardial InfarctionSignificance
- (2015) Yumei Ye et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Statin-Induced Cardioprotection Against Ischemia-Reperfusion Injury: Potential Drug-Drug Interactions. Lesson to be Learnt by Translating Results from Animal Models to the Clinical Settings
- (2015) Gilad D. Birnbaum et al. CARDIOVASCULAR DRUGS AND THERAPY
- NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins
- (2015) Afrasyab Altaf et al. CORONARY ARTERY DISEASE
- Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
- (2015) Jesmond Dalli et al. NATURE MEDICINE
- Is immunity a mechanism contributing to statin-induced diabetes?
- (2015) Brandyn D Henriksbo et al. Adipocyte
- Chronic Treatment With Ticagrelor Limits Myocardial Infarct Size
- (2014) Manjyot K. Nanhwan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PTEN Upregulation May Explain the Development of Insulin Resistance and Type 2 Diabetes with High Dose Statins
- (2014) Yochai Birnbaum et al. CARDIOVASCULAR DRUGS AND THERAPY
- Statin-Induced Insulin Resistance Through Inflammasome Activation: Sailing Between Scylla and Charybdis
- (2014) Patricia Mitchell et al. DIABETES
- Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance
- (2014) Brandyn D. Henriksbo et al. DIABETES
- 3-Hydroxyl-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitor (Statin)-induced 28-kDa Interleukin-1β Interferes with Mature IL-1β Signaling
- (2014) Facundo Davaro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1
- (2014) Duncan Armstrong et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Phosphorylation of 5-Lipoxygenase at Ser523 by Protein Kinase A Determines Whether Pioglitazone and Atorvastatin Induce Proinflammatory Leukotriene B4 or Anti-Inflammatory 15-Epi-Lipoxin A4 Production
- (2014) Y. Ye et al. JOURNAL OF IMMUNOLOGY
- Adenosine-Mediated Effects of Ticagrelor
- (2014) Marco Cattaneo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
- (2014) Ezra A. Amsterdam et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Aspirin, Clopidogrel, and Ticagrelor in Acute Coronary Syndromes
- (2013) Jeffrey S. Berger AMERICAN JOURNAL OF CARDIOLOGY
- Exploring the Ticagrelor-Statin Interplay in the PLATO Trial
- (2013) James J. DiNicolantonio et al. CARDIOLOGY
- Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
- (2013) Beibei Luo et al. CARDIOVASCULAR DRUGS AND THERAPY
- The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
- (2013) Øystein Sandanger et al. CARDIOVASCULAR RESEARCH
- NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin
- (2013) Mamoru Satoh et al. CLINICAL SCIENCE
- Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
- (2013) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12antagonism
- (2013) S. Nylander et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Statins and Pulmonary Fibrosis
- (2012) Jin-Fu Xu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats
- (2012) Ying Fan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents
- (2012) M. Thurnher et al. CLINICAL CANCER RESEARCH
- Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: Role of iNOS and VEGF
- (2012) Sawsan A. Zaitone et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse
- (2012) Stefano Toldo et al. EXPERIMENTAL PHYSIOLOGY
- HMG-CoA reductase inhibitors activate caspase-1 in human monocytes depending on ATP release and P2X7 activation
- (2012) Y.-H. Liao et al. JOURNAL OF LEUKOCYTE BIOLOGY
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
- (2012) Patrick T. O'Gara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Deletion of the Innate Immune NLRP3 Receptor Abolishes Cardiac Ischemic Preconditioning and Is Associated with Decreased Il-6/STAT3 Signaling
- (2012) Coert J. Zuurbier et al. PLoS One
- The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
- (2011) Yumei Ye et al. BASIC RESEARCH IN CARDIOLOGY
- Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
- (2011) Masanori Kawaguchi et al. CIRCULATION
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
- (2011) E. Mezzaroma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions
- (2010) Yumei Ye et al. Annals of the New York Academy of Sciences
- Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin
- (2010) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- Determination of ticagrelor and two metabolites in plasma samples by liquid chromatography and mass spectrometry
- (2010) Henrik Sillén et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins
- (2009) Ying Yang et al. EUROPEAN JOURNAL OF HEART FAILURE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin
- (2008) Yumei Ye et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins against Ischemia–Reperfusion Injury in the Rat
- (2008) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started